544 Egerton St
London ON, N5W 3Z8
Bezalip® SR, a prescription medication is a modified-release tablet that contains the active ingredient bezafibrate, which is a type of medicine known as a fibrate. Bezalip® SR is indicated as an adjunct to diet and other therapeutic measures for mixed hyperlipidemia. Hyperlipidemia is defined as the elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high-density lipoprotein (HDL) level that contributes to the development of atherosclerosis. Causes may be primary (genetic) or secondary. Diagnosis is by measuring plasma levels of total cholesterol, TGs, and individual lipoproteins. Treatment is dietary changes, exercise, and may include lipid-lowering drugs.
Canadian Heart and Stroke Foundation
American Heart Association